GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Ending Cash Position

Toleranzia AB (OSTO:TOL) Ending Cash Position : kr9.75 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Toleranzia AB Ending Cash Position?

Toleranzia AB's Ending Cash Position for the quarter that ended in Mar. 2024 was kr9.75 Mil.

Toleranzia AB's quarterly Ending Cash Position declined from Sep. 2023 (kr32.51 Mil) to Dec. 2023 (kr18.30 Mil) and declined from Dec. 2023 (kr18.30 Mil) to Mar. 2024 (kr9.75 Mil).

Toleranzia AB's annual Ending Cash Position declined from Dec. 2021 (kr76.28 Mil) to Dec. 2022 (kr33.94 Mil) and declined from Dec. 2022 (kr33.94 Mil) to Dec. 2023 (kr18.30 Mil).

Toleranzia AB Ending Cash Position Historical Data

The historical data trend for Toleranzia AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Toleranzia AB Ending Cash Position Chart

Toleranzia AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 20.86 43.15 76.28 33.94 18.30

Toleranzia AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.60 0.70 32.51 18.30 9.75

Toleranzia AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Toleranzia AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=33.937+-15.633
=18.30

Toleranzia AB's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=18.304+-8.557
=9.75

Toleranzia AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Toleranzia AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Toleranzia AB (OSTO:TOL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Toleranzia AB (OSTO:TOL) » Definitions » Ending Cash Position
Comparable Companies
XSAT:DANCAN OSTO:NANEXA OSTO:MOB OSTO:ERMA OSTO:ALZCUR XSAT:PMED OSTO:NEWBRY XSAT:ODI OSTO:GABA XSAT:ACUC XTER:MRK ZTS TSE:4502 NSE:SUNPHARMA CTLT TSE:4507 SHSE:600196 SZSE:000538 VTRS NSE:DIVISLAB
Traded in Other Exchanges
N/A
Address
Erik Dahlbergsgatan 11A, Gothenburg, SWE, SE-411 26
Website
https://www.toleranzia.com
Toleranzia AB is a pharmaceutical company based in Sweden. The company's drug candidate, TOL2, is being developed for the treatment of the autoimmune neuromuscular disease myasthenia gravis, an orphan disease.